We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 23, 2020

Adverse Events Related to Abiraterone and Enzalutamide Treatment

Prostate Cancer and Prostatic Diseases

 

Additional Info

Disclosure statements are available on the authors' profiles:

Prostate Cancer and Prostatic Diseases
Adverse Events Related to Abiraterone and Enzalutamide Treatment: Analysis of the EudraVigilance Database and Meta-Analysis of Registrational Phase III Studies
Prostate Cancer Prostatic Dis. 2020 Jun 01;23(2)199-206, C De Nunzio, R Lombardo, G Tema, O Voglino, A Sica, V Baldassarri, A Nacchia, R Iacovelli, S Bracarda, A Tubaro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading